Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion

PHASE4RecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

December 18, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions

Lactation SuppressedSecond Trimester Abortion

Interventions

DRUG

Cabergoline

1mg oral cabergoline given to participants once

DRUG

Placebo

1 encapsulated placebo tablet given to participants after procedure

Trial Locations (1)

RECRUITING

Northwestern Medical Center, Chicago

All Listed Sponsors

lead

Northwestern University

OTHER